Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we established in vivo osteo-organoids triggered by bone morphogenetic protein-2-loaded gelatin scaffolds to harvest therapeutic hematopoietic stem/progenitor cells for the reconstruction of a damaged hematopoietic and immune system. Overall, this approach can provide a promising cell source for cell therapies.

Abstract

Hematopoietic stem cell transplantation (HSCT) requires a sufficient number of therapeutic hematopoietic stem/progenitor cells (HSPCs). To identify an adequate source of HSPCs, we developed an in vivo osteo-organoid by implanting scaffolds loaded with recombinant human bone morphogenetic protein-2 (rhBMP-2) into an internal muscle pouch near the femur in mice. After 12 weeks of implantation, we retrieved the in vivo osteo-organoids and conducted flow cytometry analysis on HPSCs, revealing a significant presence of HSPC subsets within the in vivo osteo-organoids.

We then established a sublethal model of hematopoietic/immune system injury in mice through radiation and performed hematopoietic stem cell transplantation (HSCT) by injecting the extracted osteo-organoid-derived cells into the peripheral blood of radiated mice. The effect of hematopoietic recovery was evaluated through hematological, peripheral blood chimerism, and solid organ chimerism analyses. The results confirmed that in vivo osteo-organoid-derived cells can rapidly and efficiently reconstruct damaged peripheral and solid immune organs in irradiated mice. This approach holds potential as an alternative source of HSPCs for HSCT, offering benefits to a larger number of patients.

Introduction

Hematopoietic stem cell transplantation stands as the conventional therapy for a variety of hematological malignancies, as well as numerous inherited and autoimmune disorders1,2,3,4. Nevertheless, the restricted quantity and origin of hematopoietic stem/progenitor cells (HSPCs) have emerged as a substantial impediment to the clinical implementation of hematopoietic stem cell transplantation (HSCT)5,6.

Large-scale in vitro cel....

Protocol

Male and female C57BL/6 mice, aged 8-10 weeks, were included in the study. All mice were housed in the animal facility of East China University of Science and Technology. All the experimental procedures were approved by the Institutional Animal Care and Use Committees of East China University of Science and Technology (ECUST-21010).

1. Fabrication of bioactive scaffold

  1. Preparation
    1. Put the cleaned and dried surgical scissors and tweezers into a 1,000 mL .......

Representative Results

As per the protocol, we have created a bioactive scaffold by dripping BMP-2 into a degradable gelatin sponge under sterile conditions. The scaffold was then implanted into the lower limb muscles of mice to establish in vivo osteo-organoids. After an incubation period of 12 weeks, we conducted macroscopic photography, histological analysis, and flow cytometry analysis on the osteo-organoids (Figure 1A). The gelatin sponge was cut into cubes with dimensions of 5 mm x 5 mm x 5 mm, and .......

Discussion

In this protocol, we present an approach to establish in vivo osteo-organoids with bone marrow-like structures by implanting gelatin sponge scaffolds loaded with BMP-2. We demonstrate that these in vivo osteo-organoids can stably produce therapeutic HSPCs over a long period of time (more than 12 weeks). Compared to existing in vitro expansion or in vivo incubation methods that load cells, this protocol can obtain cell cocktails with diverse cell types, including HSPCs and various immun.......

Acknowledgements

This research was supported by the Basic Science Center Program (No. T2288102), the Key Program of the National Natural Science Foundation of China (No. 32230059), the National Natural Science Foundation of China (No. 32301123), the Foundation of Frontiers Science Center for Materiobiology and Dynamic Chemistry (No. JKVD1211002), the Wego Project of Chinese Academy of Sciences (No. (2020) 005), the Project of National Facility for Translational Medicine (Shanghai) (No. TMSK-2021-134), and the China Postdoctoral Science Foundation (No. 2022M721147).

....

Materials

NameCompanyCatalog NumberComments
AF700-anti-CD11b (M1/70)eBioscience56-0112-82Store at 4 °C. Dilute 1:200 for staining.
AF700-anti-Sca-1 (D7)BioLegend108141Store at 4 °C. Dilute 1:200 for staining.
APC-anti-CD3e (145-2C11)Tonbo20-0031-U100Store at 4 °C. Dilute 1:200 for staining.
bio-anti-CD34 (RAM34)eBioscience13-0341-82Store at 4 °C. Dilute 1:200 for staining.
BV421-anti-CD127 (IL-7Rα)BioLegend135023Store at 4 °C. Dilute 1:200 for staining.
BV510-anti-CD48 (HM48-1)BioLegend103443Store at 4 °C. Dilute 1:200 for staining.
BV711-anti-CD16/32 (93)BioLegend101337Store at 4 °C. Dilute 1:200 for staining.
Capillary tube Shanghai Huake Labware Co.DC616297403604-100mm/0.5mm
Cell strainerCORNING352340
EthanolGENERAL-REAGENT01158566
Ethylenediamine tetraacetic acid (EDTA) solutionServicebioG1105
Ethylenediaminetetraacetic acid dipotassium salt dihydrate (EDTA-K2)SolarbioE8651
FITC-anti-CD45.2 (104)BioLegend109806Store at 4 °C. Dilute 1:200 for staining.
FlowjoBecton, Dickinson & CompanyA flow cytometry.
Gelatin spongeJiangxi Xiangen Co.Use under sterile conditions.
HBSS without Ca2+ and Mg2+Gibco14170112HBSS without Ca2+ and Mg2+ can prevent cell aggregation.
Hematology analyzerSysmexpocH-100i Diff
iodine swabsXiangtan Mulan Biological Technology Co., Ltd.01011To prevent the infection after operation.
IsofluraneRWDR510-22-10 To avoid adverse effects of anesthesia waste gases on the environment and laboratory personnel, a gas recovery system should be used in conjunction.
Kraft paperabsorbent paper
LIVE/DEAD Fixable Near IR Dead Cell Staining Kit(used in 3.4.5)Thermo Fisher ScientificL34962A live/dead staining kit. Store at -20 °C. Dissolve in 50 μL of DMSO for working solution.
lubricating vet ointmentPfizerTo prevent dryness and counteract the ocular irritations caused by isoflurane.
Neutral balsamSolarbioG8590
nylon filterShanghai Shangshai Wire Mesh Manufacturing Co., Ltd.Used for cell filtration.
Paraffin liquidMacklinP815706
Paraformaldehyde (PFA) solutionServicebioG1101Immersion fixation is used for routine animal tissues. The volume of fixative used is generally 10-20 times the tissue volume, and fixation at room temperature for 24 hours is sufficient.
PE-anti-CD45.1 (A20)BioLegend110708Store at 4 °C. Dilute 1:200 for staining.
PE-CF594-anti-CD135 (A2F10.1)BD Biosciences562537Store at 4 °C. Dilute 1:200 for staining.
PE-Cy5-anti-c-kit (2B8)BD Biosciences105809Store at 4 °C. Dilute 1:200 for staining.
PE-Cy7-anti-B220 (RA3-6B2)BioLegend103222Store at 4 °C. Dilute 1:200 for staining.
PE-Cy7-anti-CD150 (TC15-12F12.2)BioLegend115914Store at 4 °C. Dilute 1:200 for staining.
PE-Dazzle594-anti-CD4 (GK1.5)BioLegend100456Store at 4 °C. Dilute 1:200 for staining.
Pentobarbital sodium saltSigma-Aldrich57-33-0Prepare for use at a concentration of 1% (w/v).
PerCp-Cy5.5-anti-CD8a (53-6.7)BioLegend100734Store at 4 °C. Dilute 1:200 for staining.
PerCp-Cy5.5-anti-lineage cocktailBD Biosciences561317Store at 4 °C. Dilute 1:10  for staining.
Red blood cell lysis bufferBeyotimeC3702Store at 4 °C. Use in clean bench.
rhBMP-2Shanghai Rebone Biomaterials Co.The concentration of rhBMP-2 in the stock solution is 1.0 mg/mL.
Staining bufferBioLegend420201Store at 4 °C.
XyleneGENERAL-REAGENT01018114
Zombie UV Fixable Viability Kit (used in 6.2.5)BioLegend423108A live/dead staining kit. For reconstitution, bring the kit to room temperature; add 100 µL of DMSO to one vial of Zombie UV dye until fully dissolved. 

References

  1. Copelan, E. A. Hematopoietic stem-cell transplantation. New England Journal of Medicine. 354 (17), 1813-1826 (2006).
  2. Vittayawacharin, P., et al. Autologous hematopoietic stem cell transplantation for a patient with....

Explore More Articles

In Vivo Osteo organoidHematopoietic Stem progenitor CellsHSCTRhBMP 2Hematopoietic RecoveryPeripheral Blood ChimerismSolid Organ ChimerismAlternative HSPC Source

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved